Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > EBITDA Margin

Aquestive Therapeutics Inc EBITDA Margin Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly EBITDA Margin from 2006 to 2018. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Aquestive Therapeutics Inc EBITDA Margin for the quarter ending December 12, 2018 was $-69m a 139.08% decrease of -96m year over year
  • Aquestive Therapeutics Inc EBITDA Margin for the last 12 months ending December 12, 2018 was $-31m a 136.82% decrease of -42m year over year
  • Aquestive Therapeutics Inc Annual EBITDA Margin for 2018 was $-31m a 118.52% decrease of -36m from 2017
  • Aquestive Therapeutics Inc Annual EBITDA Margin for 2017 was $6m a -6.87% decrease of 0m from 2016
  • Aquestive Therapeutics Inc Annual EBITDA Margin for 2016 was $6m a 2,510.20% increase of 153m from 2015
Other Margins & Efficiency Metrics:
  • Aquestive Therapeutics Inc Return on Capital % for the quarter ending December 12, 2018 was -48.42 a -5.35% increase of 2.59 year over year
  • Aquestive Therapeutics Inc Return on Equity % for the quarter ending December 12, 2018 was -332.75
View Chart On Koyfin

Quarterly AQST EBITDA Margin Data

12/2018$-69m
09/2018$-64m
06/2018$-229m
03/2018$27m
12/2017$-51m
09/2017$42m
06/2017$-28m
03/2017$11m
06/2007$-200m
03/2006$-124m

Annual AQST EBITDA Margin Data

2018$-31m
2017$6m
2016$6m
2004$-147m